FDA recalls multiple blood pressure medications for potential cancer risk – WIS10

FDA recalls multiple blood pressure medications for potential cancer risk - WIS10 thumbnail

By Randy Buffington | September 23, 2019 at 6: 34 AM EDT – Up-to-the-minute September 23 at 10: 21 AM

CLEVELAND, Ohio (WOIO) – Several blood stress medicines had been recalled after publicity that might perhaps perhaps well additionally pose a most cancers risk.

Torrent Prescribed medicines Restricted offered Thursday it is growing its have interaction for Losartan Potassium Capsules USP and Losartan Potassium / hydrochlorothiazide medicines, USP, after hint quantities of N-Methylnitrosobutyric acid (NMBA) was detected.

Torrent Prescribed medicines Restricted is recalling the next medicines:

Losartan Potassium Capsules, USP 50mg, 1000 count

  • NDC: 13668-409-10
  • Batch No.: 4DU2E009
  • Expiration: 12/31/2020

Losartan Potassium Capsules, USP 100mg, 90 count

  • NDC: 13668-115-90
  • Batch No.: 4DU3E009
  • Expiration: 12/31/2020

Losartan Potassium Capsules, USP 100mg, 1000 count

  • NDC: 13668-115-10
  • Batch No.: 4DU3D018
  • Expiration: 02/28/2021

Losartan Potassium / Hydrochlorothiazide Capsules, USP 50mg/12.5mg, 90 count

  • NDC: 13668-116-90
  • Batch No.: BEF7D051
  • Expiration: 11/30/2020

Losartan Potassium / Hydrochlorothiazide Capsules, USP 100mg/25mg, 90 count

  • NDC: 13668-118-90
  • Batch No.: 4P04D007
  • Expiration: 07/31/2020

Someone with questions can contact Torrent Prescribed medicines Restricted at (800) 912-9561.

Copyright 2019 WOIO. All rights reserved.

Read Extra

Leave a comment

Sign in to post your comment or sign-up if you don't have any account.

yeoys logo